Pfizer-BioNTech vaccine could be ready for approval by mid-October — but there are still 'unknowns' edition.cnn.com

Pfizer and BioNTech are confident they can have a vaccine against the novel coronavirus ready for regulatory approval by the middle of October or early November, BioNTech CEO and co-founder Ugur Sahin told CNN Tuesday.